Intratumoral lymph vessel invasion as a predictive risk factor for nodal metastasis in non-small cell lung cancer: should L-1 status obligate adjuvant chemotherapy?

Affiliations

Editorial

Kimberly J Song et al. J Thorac Dis. 2019 Sep.

. 2019 Sep;11(Suppl 15):S1990-S1991.

doi: 10.21037/jtd.2019.06.73.

¹ Department of Thoracic Surgery, Mount Sinai Health System, Icahn School of Medicine, New York, NY, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Predictive risk factors for lymph node metastasis in patients with resected non-small cell lung cancer: a case control study.
Moulla Y, Gradistanac T, Wittekind C, Eichfeld U, Gockel I, Dietrich A. Moulla Y, et al. J Cardiothorac Surg. 2019 Jan 16;14(1):11. doi: 10.1186/s13019-019-0831-0. J Cardiothorac Surg. 2019. PMID: 30651112 Free PMC article.

1. Moulla Y, Gradistanac T, Wittekind C, et al. Predictive risk factors for lymph node metastasis in patients with resected non-small cell lung cancer: a case control study. J Cardiothorac Surg 2019;14:11. 10.1186/s13019-019-0831-0 - DOI - PMC - PubMed
1. Graham AN, Chan KJ, Pastorino U, et al. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 1999;117:246-51. 10.1016/S0022-5223(99)70419-8 - DOI - PubMed
1. De Leyn P, Dooms C, Kuzdzal J, et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg 2014;45:787-98. 10.1093/ejcts/ezu028 - DOI - PubMed
1. Turna A, Melek H, Kara HV, et al. Validity of the updated European Society of Thoracic Surgeons staging guideline in lung cancer patients. J Thorac Cardiovasc Surg 2018;155:789-95. 10.1016/j.jtcvs.2017.09.090 - DOI - PubMed
1. Lee PC, Port JL, Korst RJ, et al. Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg 2007;84:177-81. 10.1016/j.athoracsur.2007.03.081 - DOI - PubMed